Marc Campayo

555 total citations
23 papers, 400 citations indexed

About

Marc Campayo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Marc Campayo has authored 23 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Marc Campayo's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Marc Campayo is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Marc Campayo collaborates with scholars based in Spain, United States and Palestinian Territory. Marc Campayo's co-authors include Mariano Monzó, Alfons Navarro, Núria Viñolas, Ramón M. Marrades, José Ramírez, Rut Tejero, Tania Díaz, Laureano Molins, Sandra Santasusagna and Josep María Gimferrer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Marc Campayo

19 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Campayo Spain 9 300 289 77 65 27 23 400
Wenfan Fu China 11 280 0.9× 215 0.7× 80 1.0× 59 0.9× 16 0.6× 16 367
Yusaku Osako Japan 9 309 1.0× 266 0.9× 89 1.2× 44 0.7× 37 1.4× 13 400
Zanxi Fang China 10 262 0.9× 203 0.7× 63 0.8× 42 0.6× 27 1.0× 18 363
Emily Tsaroucha Greece 7 492 1.6× 441 1.5× 65 0.8× 56 0.9× 13 0.5× 11 569
Qian Fei China 10 171 0.6× 151 0.5× 48 0.6× 48 0.7× 26 1.0× 19 264
Shengda Cao China 12 229 0.8× 179 0.6× 46 0.6× 42 0.6× 31 1.1× 30 302
Maria Moksnes Bjaanæs Norway 8 235 0.8× 190 0.7× 59 0.8× 80 1.2× 11 0.4× 24 332
Shize Yang China 10 265 0.9× 198 0.7× 60 0.8× 89 1.4× 25 0.9× 18 344
Qijue Lu China 11 342 1.1× 226 0.8× 69 0.9× 82 1.3× 62 2.3× 22 451
Xiaoyong Cai China 10 223 0.7× 236 0.8× 54 0.7× 72 1.1× 47 1.7× 25 344

Countries citing papers authored by Marc Campayo

Since Specialization
Citations

This map shows the geographic impact of Marc Campayo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Campayo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Campayo more than expected).

Fields of papers citing papers by Marc Campayo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Campayo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Campayo. The network helps show where Marc Campayo may publish in the future.

Co-authorship network of co-authors of Marc Campayo

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Campayo. A scholar is included among the top collaborators of Marc Campayo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Campayo. Marc Campayo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benítez, José Carlos, Marc Campayo, Tania Díaz, et al.. (2021). Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer. Journal of Personalized Medicine. 11(5). 420–420. 5 indexed citations
2.
Benítez, José Carlos, Marc Campayo, Sergi Call, & R. Bastús. (2018). Mesotelioma pleural maligno: experiencia de los últimos 8 años en nuestra área. Archivos de Bronconeumología. 54(12). 637–638.
3.
Benítez, José Carlos, et al.. (2018). Leptomeningeal Carcinomatosis in a Patient With Clinical Stage III Lung Adenocarcinoma and Sudden Neurological Impairment. Archivos de Bronconeumología. 54(6). 344–345.
4.
Suárez, Cristina, Marc Campayo, R. Bastús, et al.. (2018). Prognostic and Predictive Factors for Renal Cell Carcinoma. Targeted Oncology. 13(3). 309–331. 7 indexed citations
5.
Campayo, Marc, Alfons Navarro, José Carlos Benítez, et al.. (2018). miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer. PLoS ONE. 13(11). e0206542–e0206542. 36 indexed citations
6.
Gallardo, Enrique, María José Méndez-Vidal, José Luis Perez‐Gracia, et al.. (2017). SEOM clinical guideline for treatment of kidney cancer (2017). Clinical & Translational Oncology. 20(1). 47–56. 13 indexed citations
7.
8.
Cabrera, Cecilia, María J. Arranz, Antonio Salas, et al.. (2016). Genetic influence of EGFR-PI3K-mTOR pathway and other loci in triple-negative breast cancer. Annals of Oncology. 27. vi33–vi33.
9.
Pérez‐Valderrama, Begoña, Begoña Mellado, María Ochoa de Olza, et al.. (2015). Weekly cabazitaxel in "unfit" metastatic castration-resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment: Preliminary results of CABASEM-SOGUG phase II trial.. Journal of Clinical Oncology. 33(7_suppl). 167–167. 3 indexed citations
10.
Tejero, Rut, Alfons Navarro, Marc Campayo, et al.. (2014). miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma. PLoS ONE. 9(7). e101899–e101899. 114 indexed citations
11.
Pérez‐Valderrama, Begoña, Begoña Mellado, E. Fernández-Parra, et al.. (2014). Preliminary Results of a Phase Ii Study of Weekly Cabazitaxel in "Unfit" Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients Progressing After Docetaxel Treatment (Sogug-Cabasem Trial). Annals of Oncology. 25. iv270–iv270. 2 indexed citations
12.
Campayo, Marc, Alfons Navarro, Núria Viñolas, et al.. (2012). Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer. European Respiratory Journal. 41(5). 1172–1178. 64 indexed citations
13.
Campayo, Marc, Núria Viñolas, Alfons Navarro, et al.. (2011). Single Nucleotide Polymorphisms in Tobacco Metabolism and DNA Repair Genes and Prognosis in Resected Non-Small-Cell Lung Cancer. Journal of Surgical Research. 167(1). e5–e12. 6 indexed citations
14.
Campayo, Marc, Alfons Navarro, Núria Viñolas, et al.. (2011). A Dual Role for KRT81: A miR-SNP Associated with Recurrence in Non-Small-Cell Lung Cancer and a Novel Marker of Squamous Cell Lung Carcinoma. PLoS ONE. 6(7). e22509–e22509. 50 indexed citations
15.
16.
Navarro, Alfons, Tania Díaz, Elena Gallardo, et al.. (2010). Prognostic implications of miR‐16 expression levels in resected non‐small‐cell lung cancer. Journal of Surgical Oncology. 103(5). 411–415. 54 indexed citations
17.
Campayo, Marc, Carme Font, B. Farrús, et al.. (2010). Venous thromboembolism (VTE) in patients with lung cancer (LC).. Journal of Clinical Oncology. 28(15_suppl). e19565–e19565. 1 indexed citations
18.
Caballero, Miguel, et al.. (2009). Gene single nucleotide polymorphism accumulation improves survival in advanced head and neck cancer patients treated with weekly paclitaxel. The Laryngoscope. 119(8). 1484–1490. 15 indexed citations
19.
20.
Ibeas, R., Mariano Monzó, Irene Moreno, et al.. (2004). Cytidine Deaminase (CD) and Dihydropyrimidine Dehydrogenase (DPD) single nucleotide polymorphisms (SNPs) in capecitabine-treated colorectal cancer (CRC). Journal of Clinical Oncology. 22(14_suppl). 3662–3662. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenfan Fu Breakdown of academic impact, for papers by Yusaku Osako Breakdown of academic impact, for papers by Zanxi Fang Breakdown of academic impact, for papers by Emily Tsaroucha Breakdown of academic impact, for papers by Qian Fei Breakdown of academic impact, for papers by Shengda Cao Breakdown of academic impact, for papers by Maria Moksnes Bjaanæs Breakdown of academic impact, for papers by Shize Yang Breakdown of academic impact, for papers by Qijue Lu Breakdown of academic impact, for papers by Xiaoyong Cai
Rankless by CCL
2026